by
Thomas Dworetzky, Contributing Reporter | June 28, 2017
The combination permits clinicians “to visualize tumors at any time and adapt the treatment accordingly,” the company said in a statement.
“Elekta Unity is a technical tour de force, through which we have overcome the long-standing limitations of operating a radiation delivery system within the high-magnetic field of a diagnostic-quality MR imaging system,” Dr. Richard Hausmann, Elekta’s president and CEO, stated at the time.
Ad Statistics
Times Displayed: 109208
Times Visited: 6638 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
In fact, at ESTRO the Elekta Unity was featured in 20 abstracts.
At a symposium titled “MR-guided radiotherapy: the new standard of care in 10 years time,” Dr. Stella Mook, a radiation oncologist at UMC Utrecht, delivered a presentation in which she discussed several ways in which
Elekta’s MR-linac will enable a new era of highly precise treatment, providing broader clinical options.
These included, Mook, advised, “that improvements in tumor targeting will allow higher doses of radiation to be delivered over fewer treatment sessions, potentially omitting the need for surgery. Daily plan adaptation based on real-time imaging may also support the development of organ-sparing treatment strategies, and would allow radiation therapy to be used in a broader number of cancer indications.”
Back to HCB News
